Skip to main content
Top
Published in: Journal of Neural Transmission 10/2015

01-10-2015 | Neurology and Preclinical Neurological Studies - Original Article

Heart rate variability shows different cardiovascular modulation in Parkinson’s disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype

Authors: Paolo Solla, Christian Cadeddu, Antonino Cannas, Martino Deidda, Nicola Mura, Giuseppe Mercuro, Francesco Marrosu

Published in: Journal of Neural Transmission | Issue 10/2015

Login to get access

Abstract

Parkinson’s disease (PD) can present with different motor subtypes depending on the predominant symptoms (tremor or rigidity/bradykinesia). Slower disease progression and less cognitive decline are observed in tremor-dominant patients compared to those with akinetic-rigid subtype. Autonomic cardiovascular disorders have been described in parkinsonian patients, although the definite correlations with different subtypes of PD are not clear. In this context, heart rate variability (HRV) analysis represents a non-invasive and established tool in assessing cardiovascular autonomic modulation. We investigate cardiovascular autonomic modulation in PD patients with tremor dominant subtype in comparison to akinetic rigid dominant subtype subjects using HRV analysis. Twenty-eight PD patients (17 with tremor dominant subtype and 11 with akinetic rigid dominant subtype) were enrolled and compared to 17 age and sex-matched healthy controls. HRV was analyzed in time- and frequency-domains. Low-frequency (LF) values were significantly lower in the akinetic rigid dominant subtype than in the tremor dominant group [LF 41.4 ± 13.6 vs 55.5 ± 11.6 (p < 0.007)] indicating that the disease led to a more evident impairment of the baroreflex modulation of the autonomic outflow mediated by both sympathetic and parasympathetic systems in the first class of patients. These findings support the biological relevance of clinical subtypes supporting the idea of a different pathophysiological process between these subtypes. These differences also suggest that different subtypes may also result in different responses to therapy or in the possible development of cardiovascular side effects of dopaminergic drugs in these different populations.
Literature
go back to reference Cadeddu C, Deidda M, Mercuro G, Tuveri A, Muroni A, Nocco S et al (2010) Cardiovascular modulation during vagus nerve stimulation therapy in patients with refractory epilepsy. Epilepsy Res 92(2–3):145–152CrossRefPubMed Cadeddu C, Deidda M, Mercuro G, Tuveri A, Muroni A, Nocco S et al (2010) Cardiovascular modulation during vagus nerve stimulation therapy in patients with refractory epilepsy. Epilepsy Res 92(2–3):145–152CrossRefPubMed
go back to reference Camm AJ, Malik M, Bigger JT et al (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing Electrophysiology. Circulation 93:1043–1065CrossRef Camm AJ, Malik M, Bigger JT et al (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing Electrophysiology. Circulation 93:1043–1065CrossRef
go back to reference Chaudhuri KR, Healy D, Schapira AHV (2006) The non-motor symptoms of Parkinson’s disease. Diagnosis and management. Lancet Neurol 5:235–245CrossRefPubMed Chaudhuri KR, Healy D, Schapira AHV (2006) The non-motor symptoms of Parkinson’s disease. Diagnosis and management. Lancet Neurol 5:235–245CrossRefPubMed
go back to reference Eggers C, Kahraman D, Fink GR, Schmidt M, Timmermann L (2011) Akinetic-rigid and tremor-dominant Parkinson’s disease patients show different patterns of FP-CIT single photon emission computed tomography. Mov Disord 26(3):416–423CrossRefPubMed Eggers C, Kahraman D, Fink GR, Schmidt M, Timmermann L (2011) Akinetic-rigid and tremor-dominant Parkinson’s disease patients show different patterns of FP-CIT single photon emission computed tomography. Mov Disord 26(3):416–423CrossRefPubMed
go back to reference Evans AH, Katzenschlager R, Paviour D, O’Sullivan JD, Appel S, Lawrence AD et al (2004) Punding in Parkinson’s disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19:397–405CrossRefPubMed Evans AH, Katzenschlager R, Paviour D, O’Sullivan JD, Appel S, Lawrence AD et al (2004) Punding in Parkinson’s disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19:397–405CrossRefPubMed
go back to reference Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198CrossRefPubMed Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198CrossRefPubMed
go back to reference Friedrich C, Rudiger H, Schmidt C, Herting B, Prieur S et al (2008) Baroreflex sensitivity and power spectral analysis in different extrapyramidal syndromes. J Neural Transm 115:1527–1536CrossRefPubMed Friedrich C, Rudiger H, Schmidt C, Herting B, Prieur S et al (2008) Baroreflex sensitivity and power spectral analysis in different extrapyramidal syndromes. J Neural Transm 115:1527–1536CrossRefPubMed
go back to reference Goetz CC (2003) The unified Parkinson’s disease rating scale (UPDRS): status and recommendations. Mov Disord 18(7):738–750CrossRef Goetz CC (2003) The unified Parkinson’s disease rating scale (UPDRS): status and recommendations. Mov Disord 18(7):738–750CrossRef
go back to reference Goldstein DS (2003) Dysautonomia in Parkinson’s disease: neurocardiological abnormalities. Lancet Neurol 2(11):669–676CrossRefPubMed Goldstein DS (2003) Dysautonomia in Parkinson’s disease: neurocardiological abnormalities. Lancet Neurol 2(11):669–676CrossRefPubMed
go back to reference Goldstein DS, Bentho O, Park MY, Sharabi Y (2011) Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes. Exp Physiol 96(12):1255–1261PubMedCentralCrossRefPubMed Goldstein DS, Bentho O, Park MY, Sharabi Y (2011) Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes. Exp Physiol 96(12):1255–1261PubMedCentralCrossRefPubMed
go back to reference Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184PubMedCentralCrossRefPubMed Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184PubMedCentralCrossRefPubMed
go back to reference Jankovic J, McDermott M, Carter J, Parkinson Study Group et al (1990) Variable expression of Parkinson’s disease: a baseline analysis of the DATATOP cohort. Neurology 40(10):1529–1534CrossRefPubMed Jankovic J, McDermott M, Carter J, Parkinson Study Group et al (1990) Variable expression of Parkinson’s disease: a baseline analysis of the DATATOP cohort. Neurology 40(10):1529–1534CrossRefPubMed
go back to reference Jellinger KA (1999) Post-mortem studies in Parkinson’s disease. Is it possible to detect brain areas for specific symptoms? J Neural Transm Suppl 56:1–29CrossRefPubMed Jellinger KA (1999) Post-mortem studies in Parkinson’s disease. Is it possible to detect brain areas for specific symptoms? J Neural Transm Suppl 56:1–29CrossRefPubMed
go back to reference Kay SM, Marple SLJ (1981) Spectrum analysis: a modern perspective. Proc IEEE 69:1380–1419CrossRef Kay SM, Marple SLJ (1981) Spectrum analysis: a modern perspective. Proc IEEE 69:1380–1419CrossRef
go back to reference Langston JW (2006) The Parkinson’s complex: parkinsonism is just the tip of the iceberg. Ann Neurol 59:591–596CrossRefPubMed Langston JW (2006) The Parkinson’s complex: parkinsonism is just the tip of the iceberg. Ann Neurol 59:591–596CrossRefPubMed
go back to reference Lewis SJG, Foltynie T, Blackwell AD, Robbins TW, Owen AM, Barker RA (2005) Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 76:343–348PubMedCentralCrossRefPubMed Lewis SJG, Foltynie T, Blackwell AD, Robbins TW, Owen AM, Barker RA (2005) Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 76:343–348PubMedCentralCrossRefPubMed
go back to reference Lewis MM, Du G, Sen S et al (2011) Differential involvement of striato- and cerebello-thalamo-cortical pathways in tremor- and akinetic/rigid-predominant Parkinson’s disease. Neuroscience 177:230–239PubMedCentralCrossRefPubMed Lewis MM, Du G, Sen S et al (2011) Differential involvement of striato- and cerebello-thalamo-cortical pathways in tremor- and akinetic/rigid-predominant Parkinson’s disease. Neuroscience 177:230–239PubMedCentralCrossRefPubMed
go back to reference Maetzler W, Karam M, Berger MF, Heger T, Maetzler C, Ruediger H, Bronzova J, Lobo PP, Ferreira JJ, Ziemssen T, Berg D (2014) Time- and frequency-domain parameters of heart rate variability and sympathetic skin response in Parkinson’s disease. J Neural Transm (Epub ahead of print) Maetzler W, Karam M, Berger MF, Heger T, Maetzler C, Ruediger H, Bronzova J, Lobo PP, Ferreira JJ, Ziemssen T, Berg D (2014) Time- and frequency-domain parameters of heart rate variability and sympathetic skin response in Parkinson’s disease. J Neural Transm (Epub ahead of print)
go back to reference Mathias CJ (1998) Cardiovascular autonomic dysfunction in parkinsonian patients. Clin Neurosci 5(2):153–166PubMed Mathias CJ (1998) Cardiovascular autonomic dysfunction in parkinsonian patients. Clin Neurosci 5(2):153–166PubMed
go back to reference Mitsui J, Saito Y, Momose T, Shimizu J, Arai N, Shibahara J et al (2006) Pathology of the sympathetic nervous system corresponding to the decreased cardiac uptake in 123I-metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease. J Neurol Sci 243(1–2):101–104CrossRefPubMed Mitsui J, Saito Y, Momose T, Shimizu J, Arai N, Shibahara J et al (2006) Pathology of the sympathetic nervous system corresponding to the decreased cardiac uptake in 123I-metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease. J Neurol Sci 243(1–2):101–104CrossRefPubMed
go back to reference Oh JY, Kim YS, Choi BH, Sohn EH, Lee AY (2009) Relationship between clinical phenotypes and cognitive impairment in Parkinsons disease. Arch Gerontol Geriatr 49:351–354CrossRefPubMed Oh JY, Kim YS, Choi BH, Sohn EH, Lee AY (2009) Relationship between clinical phenotypes and cognitive impairment in Parkinsons disease. Arch Gerontol Geriatr 49:351–354CrossRefPubMed
go back to reference Pagani M, Montano A, Porta A, Malliani A, Abboud FM, Birkett C, Somers CK (1997) Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans. Circulation 95:1441–1448CrossRefPubMed Pagani M, Montano A, Porta A, Malliani A, Abboud FM, Birkett C, Somers CK (1997) Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans. Circulation 95:1441–1448CrossRefPubMed
go back to reference Rossi C, Frosini D, Volterrani D et al (2010) Differences in nigro-striatal impairment in clinical variants of early Parkinson’s disease: evidence from a FP-CIT SPECT study. Eur J Neurol 17(4):626–630CrossRefPubMed Rossi C, Frosini D, Volterrani D et al (2010) Differences in nigro-striatal impairment in clinical variants of early Parkinson’s disease: evidence from a FP-CIT SPECT study. Eur J Neurol 17(4):626–630CrossRefPubMed
go back to reference Taki J, Yoshita M, Yamada M, Tonami N (2004) Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson’s disease and related disorders: it can be a specific marker for Lewy body disease. Ann Nucl Med 18(6):453–461CrossRefPubMed Taki J, Yoshita M, Yamada M, Tonami N (2004) Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson’s disease and related disorders: it can be a specific marker for Lewy body disease. Ann Nucl Med 18(6):453–461CrossRefPubMed
go back to reference Valappil RA, Black JE, Broderick MJ, Carrillo O, Frenette E, Sullivan SS, Goldman SM, Tanner CM, Langston JW (2010) Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson’s disease. Mov Disord 25(14):2296–2303CrossRefPubMed Valappil RA, Black JE, Broderick MJ, Carrillo O, Frenette E, Sullivan SS, Goldman SM, Tanner CM, Langston JW (2010) Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson’s disease. Mov Disord 25(14):2296–2303CrossRefPubMed
go back to reference Ziemssen T, Reichmann H (2010) Cardiovascular autonomic dysfunction in Parkinson’s disease. J Neurol Sci 289(1–2):74–80CrossRefPubMed Ziemssen T, Reichmann H (2010) Cardiovascular autonomic dysfunction in Parkinson’s disease. J Neurol Sci 289(1–2):74–80CrossRefPubMed
Metadata
Title
Heart rate variability shows different cardiovascular modulation in Parkinson’s disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype
Authors
Paolo Solla
Christian Cadeddu
Antonino Cannas
Martino Deidda
Nicola Mura
Giuseppe Mercuro
Francesco Marrosu
Publication date
01-10-2015
Publisher
Springer Vienna
Published in
Journal of Neural Transmission / Issue 10/2015
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-015-1393-5

Other articles of this Issue 10/2015

Journal of Neural Transmission 10/2015 Go to the issue

Neurology and Preclinical Neurological Studies - Original Article

Putaminal alteration in multiple sclerosis patients with spinal cord lesions

Translational Neurosciences - Original Article

Glucose regulates amyloid β production via AMPK

Neurology and Preclinical Neurological Studies - Review Article

Neuropathobiology of non-motor symptoms in Parkinson disease